Tanizawa Y, Kaku K, Araki E. et al.
Long-term safety and efficacy of tofogliflozin, a selective inhibitor of
sodium-glucose cotransporter 2, as monotherapy or in combination with other oral
antidiabetic agents in Japanese patients with type 2 diabetes mellitus:
multicenter, open-label, randomized controlled trials.
Expert Opin Pharmacother 2014;
Download Bibliographical Data